171 related articles for article (PubMed ID: 25052407)
21. FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level.
Dong A; Lin X; Bai Y; Yang B; Xu S
Clin Nucl Med; 2023 Jul; 48(7):640-642. PubMed ID: 36976639
[TBL] [Abstract][Full Text] [Related]
22. PET/triphasic contrast enhanced CT: Optimized protocol for the assessment of colorectal liver metastases.
Domínguez Ferreras E; García Vicente AM; Cano Cano JM; Molino Trinidad C; Soriano Castrejón AM; Espinosa Arrainz J
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):336-7. PubMed ID: 23583267
[No Abstract] [Full Text] [Related]
23. Lung cancer and Rosai-Dorfman's disease. A clinicopathological study.
Lutterbach J; Henne K; Pagenstecher A; Böhm J
Strahlenther Onkol; 2003 Jul; 179(7):486-92. PubMed ID: 12835886
[TBL] [Abstract][Full Text] [Related]
24. A newly designed attachment device of multipurpose frame for neuronavigator. Technical note.
Singh AK; Okudera H; Kobayashi S; Osawa M; Tokushige K
Acta Neurochir (Wien); 1994; 129(1-2):97-9. PubMed ID: 7998505
[TBL] [Abstract][Full Text] [Related]
25. Multimodality imaging in biochemical recurrence of prostate cancer: utility of (18)F-NaF PET/CT in early detection of metastasis.
Desai B; Gross ME; Jadvar H
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):231-2. PubMed ID: 22980132
[No Abstract] [Full Text] [Related]
26. Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Ochoa-Figueroa MA; Uña-Gorospe J; Allende-Riera A; Cárdenas-Negro JC; Muñoz-Iglesias J; Cabello-García D; De Sequera-Rahola M; Martínez-Gimeno E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):249-56. PubMed ID: 23067526
[TBL] [Abstract][Full Text] [Related]
27. Prostatic adenocarcinoma presenting with metastatic frontal bone involvement and orbital invasion.
Patel V; Castell FA; Akinwunmi J; Francis I; Chandrasekharan L; Malhotra R
Orbit; 2010 Aug; 29(4):213-5. PubMed ID: 20812840
[TBL] [Abstract][Full Text] [Related]
28. Mesenteric lipogranuloma mimicking malignancy at ¹⁸F-FDG PET/CT in a patient with colon cancer.
Treglia G; Rusca-Fadda T; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):56-7. PubMed ID: 24986550
[No Abstract] [Full Text] [Related]
29. [Reply to editorial comment on article "Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level <5ng/ml"].
Rioja Zuazu J; Zudaire Bergera JJ; Richter JA; Berián Polo JM
Actas Urol Esp; 2010 Jan; 34(1):12-4. PubMed ID: 20223128
[No Abstract] [Full Text] [Related]
30. Nodal Recurrence From Prostate Adenocarcinoma: Curable or Incurable?
Rodríguez-López JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):236-237. PubMed ID: 31928636
[No Abstract] [Full Text] [Related]
31. [Central neurocytoma of the right parietal and occipital lobe. Case report].
Liebert W; Szymaś J; Majewski T; Paprzycki W
Neurol Neurochir Pol; 1998; 32(1):191-9. PubMed ID: 9631391
[TBL] [Abstract][Full Text] [Related]
32. Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy.
Hayashi T; Igarashi K; Tanizawa A; Terada Y; Sekine H
Urol Int; 1998; 60(2):121-3. PubMed ID: 9563153
[TBL] [Abstract][Full Text] [Related]
33. 18FDG PET/CT imaging of schwannoma mimicking colorectal cancer metastasis.
Ortega-Candil A; Rodríguez-Rey C; Cabrera-Martín MN; García García-Esquinas M; Lapeña-Gutiérrez L; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):332-3. PubMed ID: 23434018
[No Abstract] [Full Text] [Related]
34. Penile metastases from carcinoma of the prostate.
Pandian SS; McGuire M; McClinton S; Kerr KM
Br J Urol; 1997 May; 79(5):807. PubMed ID: 9158527
[No Abstract] [Full Text] [Related]
35. Use of FDG PET-CT in prostate lesion diagnosis.
Radiol Technol; 2014; 85(5):546M-547M. PubMed ID: 24806072
[No Abstract] [Full Text] [Related]
36. FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate.
Dong A; Zhu Y; Zuo C
Clin Nucl Med; 2022 Aug; 47(8):736-738. PubMed ID: 35797631
[TBL] [Abstract][Full Text] [Related]
37. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
38. FDG-PET in the selection of brain lesions for biopsy.
Hanson MW; Glantz MJ; Hoffman JM; Friedman AH; Burger PC; Schold SC; Coleman RE
J Comput Assist Tomogr; 1991; 15(5):796-801. PubMed ID: 1885797
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary metastases in metastatic prostate cancer: host tissue-tumor cell interactions and response to hormone therapy.
Behrakis P; Koutsilieris M
Anticancer Res; 1997; 17(3A):1517-8. PubMed ID: 9179189
[TBL] [Abstract][Full Text] [Related]
40. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
